Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laredo Investment Corp was a publicly traded holding company that focused on acquiring and managing a diverse portfolio of business interests, with a significant emphasis on the healthcare and medical services sectors. During its active period, the company sought to invest in emerging medical technologies and healthcare delivery systems to capitalize on the growing demand for specialized medical care. It operated primarily as an investment vehicle rather than a direct developer of therapeutic drugs or biotechnologies. The company is no longer active, and its historical trading symbol was LRDI on the OTC Bulletin Board.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laredo Investment.